Pharmacy Update
Disclaimer: We are getting frequent COVID-related questions about drug concerns and potential interactions. This information is as of June 4, 2020. We will do our best to keep you up to date with this ever evolving situation. This is the most update information at the time of publication.
Note: There are no Food and Drug Administration
(FDA) approved therapies for treatment or prevention of COVID-19. If at all possible, it is best to have patients enrolled in a clinical trial.
In this issue:
INTERLEUKIN-6 INHIBITORS
–
Currently there is limited literature regarding IL-6 inhibitors in the treatment of COVID-19 and insufficient literature to recommend their use outside of a clinical trial setting.
IVERMECTIN AND COVID-19
–
Ivermectin is another drug that is being proposed for repurposing as a potential COVID-19 treatment option.
UPDATE: MEDFORMIN RECALL
–
Amneal Pharmaceuticals has voluntarily recalled all lots of metformin extended release, both the 500 and 750 mg strength.
